awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50081141-9017CA7D-116B-483B-9157-504A7414F474
Q50081141-9017CA7D-116B-483B-9157-504A7414F474
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50081141-9017CA7D-116B-483B-9157-504A7414F474
What is the best treatment target in axial spondyloarthritis: tumour necrosis factor α, interleukin 17, or both?
P2860
Q50081141-9017CA7D-116B-483B-9157-504A7414F474
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50081141-9017CA7D-116B-483B-9157-504A7414F474
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b86fb8cfe8ce87d30e7d015de63dfc03fbbd9e86
P2860
Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks